COVID Vaccines: What’s Available Now and What’s in the Works?
Three top vaccine producers are making newer vaccines that not only protect against the newer sublineages of COVID-19, but that also protect against other respiratory viruses.
Study Shows Positive Results for mRNA-Based Combination Influenza and COVID-19 Vaccine
A Phase I/II study evaluating the safety, tolerability and immunogenicity of Pfizer and BioNTech’s mRNA-based combination vaccine candidates for influenza and COVID-19 among healthy adults 18 to 64 years of age show positive topline results.
HHS Awards $45 Million in Grants to Expand Access to Care for People with Long COVID
The U.S. Department of Health and Human Services announced nine grant awards $1 million each for up to five years to support existing multidisciplinary Long COVID clinics across the country.
HHS Forms the Office of Long COVID Research and Practice and Launch of Long COVID Clinical Trials
The U.S. Department of Health and Human Services has founded the Office of Long COVID Research and Practice to lead the Long COVID response and coordination across the federal government. In addition, the National Institutes of Health launched Long COVID clinical trials through the RECOVER Initiative.
HHS Issues Amendment to PREP Act for Medical Countermeasures Against COVID-19
The U.S. Department of Health and Human Services (HHS) has issued an amendment to the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19.
FDA Retires Monovalent COVID-19 Vaccines
The U.S. Food and Drug Administration has amended the emergency use authorizations of the. Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals.
COVID-19 Year Three: How Medical Professionals Can Balance Life, Family and Practice
Is finding a healthy work-life balance possible in the post-pandemic world?
New Test Identifies Patients at Risk of Severe COVID-19
U.S. scientists have developed a new genomic test that can predict a patient’s risk of developing severe COVID-19, an advance that could help doctors quickly begin tailored treatment.
Combination COVID-19 and Influenza Vaccine Under Development
Despite technical challenges, some companies are working on making a combination COVID and flu vaccine.
Vaccine Passports: Vaccination Confirmation or a Privacy Concern?
The implementation of vaccine passports in response to the COVID-19 pandemic has raised arguments for and against them.
